The mucosal immune system: How clear is the pathophysiology?;Das mukosale immunsystem: Wie klar ist die pathophysiologie?

Internist

Volumn 43, Issue 11, 2002, Pages 1343-1353

  Holtmann, M ^a   Mudter, J ^a   Galle, P R ^a   Neurath, M F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NEUTROPHIL CYTOPLASMIC ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; BACTERIAL INFECTION; CARBOXY TERMINAL SEQUENCE; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EPITHELIUM; GASTROINTESTINAL TRACT; GENE; GENE MUTATION; HELPER CELL; HEREDITY; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENCE; LAMINA PROPRIA; MACROPHAGE; MUCOSAL IMMUNITY; NOD2 GENE; PATHOPHYSIOLOGY; PEYER PATCH; PHYSIOLOGY; REMISSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CELL ADHESION MOLECULES; CHEMOKINES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036870010     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0681-y     Document Type: Review

References (57)

1. Podolsky DK (1991) Inflammatory bowel disease. N Engl J Med 325: 928-937
2. Friedman S, Blumberg RS (1999) Inflammatory bowel disease. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds) Harrison's Principles of Internal Medicine, 15th Edn. McGraw Hill, New York, pp 1679-1691
3. Shanahan F (2001) Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120: 622-635
4. Hugot JP, Chamaillard M, Zouali H et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603
5. Ogura Y, Bonen DK, Inohara N et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606
6. Sandborn WJ, Landers CJ,Tremaine WJ, Targan SR (1996) Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: Results of a pilot study. Mayo Clin Proc 71: 431-436
7. Sandborn WJ, Landers CJ,Tremaine WJ, Targan SR (1995) Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 90: 740-747
8. Gordon LK, Eggena M, Targan SR, Braun J (1999) Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. Invest Ophthalmol Vis Sci 40: 1250-1255
9. Gordon LK, Eggena M, Targan SR, Braun J (2000) Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin Immunol 94: 42-50
10. Cohavy O, Bruckner D, Gordon LK et al. (2000) Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 68: 1542-1548
11. Vashishtha A, Fischetti VA (1993) Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol 150: 4693-4701
12. Srivastava ED, Barton JR, O'Mahony S et al. (1991) Smoking, humoral immunity, and ulcerative colitis. Gut 32: 1016-1019
13. Cope GF, Heatley RV, Kelleher JK (1986) Smoking and colonic mucus in ulcerative colitis. BMJ (Clin Res Ed) 293: 481
14. Madretsma S, Wolters LM, van Dijk JP et al. (1996) In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol 8: 1017-1020
15. Levenstein S, Prantera C, Varvo V et al. (2000) Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission. Am J Gastroenterol 95: 1213-1220
16. Herbert TB, Cohen S (1993) Stress and immunity in humans: A meta-analytic review. Psychosom Med 55: 364-379
17. Qiu BS, Vallance BA, Blennerhassett PA, Collins SM (1999) The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 5: 1178-1182
18. Shanahan F (2000) Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflamm Bowel Dis 6: 107-115
19. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262-267
20. Sartor RB (1998) Postoperative recurrence of Crohn's disease: The enemy is within the fecal stream. Gastroenterology 114: 398-407
21. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D (1994) Inflammatory bowel disease and domestic hygiene in infancy. Lancet 343: 766-767
22. Elliott DE, Urban JJ, Argo CK, Weinstock JV (2000) Does the failure to acquire helminthic parasites predispose to Crohn's disease? Faseb J 14: 1848-1855
23. Sartor RB (1997) Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 11 (Suppl): 17-22, discussion 22-23
24. Swidsinski A, Ladhoff A, Pernthaler A et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54
25. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 102: 448-455
26. Lodinova-Zadnikova R, Sonnenborn U (1997) Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 71: 224-232
27. Trebichavsky I et al. (1998) Association of germ-free piglets with two non-pathogneic E. coli strains: Nissle 1917 stimulated the immune system more than 096 strain. J Mol Med 76: B9
28. Qiao L, Schurmann G, Betzler M, Meuer SC (1991) Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 101: 1529-1536
29. Targan SR, Deem RL, Liu M, Wang S, Nel A (1995) Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol 154: 664-675
30. Braunstein J, Qiao L, Autschbach F, Schurmann G, Meuer S (1997) T cells of the human intestinal lamina propria are high producers of interleukin-10. Gut 41: 215-220
31. Boirivant M, Pica R, DeMaria R, Testi R, Pallone F, Strober W (1996) Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest 98: 2616-2622
32. Andersson RE, Olaison G, Tysk C, Ekbom A (2001) Appendectomy and protection against ulcerative colitis. N Engl J Med 344: 808-814
33. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK (1996) Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med 184: 707-715
34. Shanahan F (2000) Mechanisms of imunologic sensation of intestinal contents. Am J Physiol 278: G191-G196
35. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-672
36. Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017
37. Rescigno M, Urbano M, Valzasina B et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2: 361-367
38. Watanabe M, Ueno Y, Yajima T et al. (1995) Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 95: 2945-2953
39. Strober W, Neurath M (1995) Immunological Diseases of the Gastrointestinal Tract. Mosby, St. Louis
40. Rogler G, Brand K, Vogl D et al. (1998) Nuclear factor kappa B is activated in macrophages and epitheleal cells of inflamed intestinal mucosa Gastroenterology 115: 357-369
41. Fuss IJ, Neurath M, Boirivant M et al. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261-1270
42. Plevy SE, Landers CJ, Prehn J et al. (1997) A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159: 6276-6282
43. Autschbach F, Braunstein J, Helmke B et al. (1998) In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 153: 121-130
44. Boirivant M, Marini M, Di Felice G et al. (1999) Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 116: 557-565
45. Ina K, Itoh J, Fukushima K et al. (1999) Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 163: 1081-1090
46. Atreya R, Mudter J, Finotto S et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in crohn disease and experimental colitis in vivo. Nat Med 6: 583-588
47. Monteleone G, Biancone L, Marasco R et al. (1997) Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112: 1169-1178
48. Christ AD, Stevens AC, Koeppen H et al. (1998) An interleukin 12-related cytokine is upregulated in ulcerative colitis but not in Crohn's disease. Gastroenterology 115: 307-313
49. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182: 1281-1290
50. Holtmann MH, Galle PR, Neurath MF (2001) Immunotherapeutic approaches to inflammatory bowel diseases. Expert Opin Biol Ther 1: 455-466
51. Beutler B (1992) Tumor Necrosis Factors: The Molecules and their Emerging Role in Medicine. Raven, New York
52. Grell M, Douni E, Wajant H et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802
53. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396: 77-80
54. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290
55. Holtmann MH, Douni E, Schütz M et al. (2002) Tumor Necrosis Factor-receptor 2 is Upregulated on Lamina Propria Mononuclear Cells in Crohn's Disease and Promotes Experimental Colitis in Vivo. (submitted)
56. Sandborn WJ, Hanauer SB, Katz S et al. (2001) Etanercept for active crohn's disease: A randomized, double-blind, placebo-controlled trial. Gastroenterology 121: 1088-1094
57. Neurath MF, Finotto S, Glimcher LH (2002) The role of Th1/Th2 polarization in mucosal immunity. Nature Med 8: 567-573